Pre-order Enquiry
Request Free Sample
Global Hormone Replacement Therapy (HRT) Market Size, Status and Forecast 2019-2025
SKU ID : QYR-14449756 | Publishing Date : 15-Jul-2019 | No. of pages : 95
Request Sample
Request Customization
Check Discounts
Hormone replacement therapy (HRT), also known as menopausal hormone therapy (MHT) or postmenopausal hormone therapy (PHT, PMHT), is a form of hormone therapy which is used to treat symptoms associated with menopause in women. These symptoms can include hot flashes, vaginal atrophy and dryness, and bone loss, among others, and are caused by diminished levels of sex hormones in the menopausal period.
The testosterone replacement therapy is majorly opted by geriatric male patients suffering from hypogonadism. Certain impact rendering drivers include aggressive direct selling campaigns by the company to individuals desiring a quality life, increasing product availability, and development of new gel-based formulations.
In 2018, the global Hormone Replacement Therapy (HRT) market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Hormone Replacement Therapy (HRT) status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Hormone Replacement Therapy (HRT) development in United States, Europe and China.
The key players covered in this study
Abbott Laboratories
Novartis
Pfizer
Mylan Laboratories
Merck & Co.
Amgen
Novo Nordisk
Bayer
Eli Lily
Wyeth
Genentech
Market segment by Type, the product can be split into
Oral
Parenteral
Transdermal
Others
Market segment by Application, split into
Menopause
Hypothyroidism
Male Hypogonadism
Growth Hormone Deficiency
Others
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Hormone Replacement Therapy (HRT) status, future forecast, growth opportunity, key market and key players.
To present the Hormone Replacement Therapy (HRT) development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Hormone Replacement Therapy (HRT) are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
The testosterone replacement therapy is majorly opted by geriatric male patients suffering from hypogonadism. Certain impact rendering drivers include aggressive direct selling campaigns by the company to individuals desiring a quality life, increasing product availability, and development of new gel-based formulations.
In 2018, the global Hormone Replacement Therapy (HRT) market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Hormone Replacement Therapy (HRT) status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Hormone Replacement Therapy (HRT) development in United States, Europe and China.
The key players covered in this study
Abbott Laboratories
Novartis
Pfizer
Mylan Laboratories
Merck & Co.
Amgen
Novo Nordisk
Bayer
Eli Lily
Wyeth
Genentech
Market segment by Type, the product can be split into
Oral
Parenteral
Transdermal
Others
Market segment by Application, split into
Menopause
Hypothyroidism
Male Hypogonadism
Growth Hormone Deficiency
Others
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Hormone Replacement Therapy (HRT) status, future forecast, growth opportunity, key market and key players.
To present the Hormone Replacement Therapy (HRT) development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Hormone Replacement Therapy (HRT) are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
